Matches in DBpedia 2016-04 for { ?s ?p "Ionis Pharmaceuticals (NASDAQ: IONS), known as ISIS Pharmeceuticals until December 2015, is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy."@en }
Showing triples 1 to 4 of
4
with 100 triples per page.
- Ionis_Pharmaceuticals abstract "Ionis Pharmaceuticals (NASDAQ: IONS), known as ISIS Pharmeceuticals until December 2015, is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy.".
- Q22079531 abstract "Ionis Pharmaceuticals (NASDAQ: IONS), known as ISIS Pharmeceuticals until December 2015, is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy.".
- Ionis_Pharmaceuticals comment "Ionis Pharmaceuticals (NASDAQ: IONS), known as ISIS Pharmeceuticals until December 2015, is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy.".
- Q22079531 comment "Ionis Pharmaceuticals (NASDAQ: IONS), known as ISIS Pharmeceuticals until December 2015, is a publicly traded pharmaceutical company based in Carlsbad, California, United States. It has a single cholesterol-reducing drug in the market and several compounds in the drug pipeline.The company was founded in 1989 by Stanley Crooke, a former GlaxoSmithKline head of research, with a view to commercialize antisense therapy.".